I. Press, “Reprogramming the Enemy Within: Patient-Derived CAR-T Cells Effectively Target Inflammation-Inducing B cells”, MJUSc, vol. 4, no. 1, pp. 13–14, Sep. 2025, doi: 10.17161/mjusc.v4i1.24543.